Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Innoviva Inc (INVA)

Innoviva Inc (INVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 898,805
  • Shares Outstanding, K 69,783
  • Annual Sales, $ 391,870 K
  • Annual Income, $ 265,850 K
  • 60-Month Beta 0.59
  • Price/Sales 2.30
  • Price/Cash Flow 2.81
  • Price/Book 1.42
Trade INVA with:

Options Overview Details

View History
  • Implied Volatility 36.79% ( +5.19%)
  • Historical Volatility 31.29%
  • IV Percentile 12%
  • IV Rank 30.02%
  • IV High 76.14% on 10/07/22
  • IV Low 19.91% on 09/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 2,884
  • Open Int (30-Day) 2,916

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.54
  • Number of Estimates 1
  • High Estimate 0.54
  • Low Estimate 0.54
  • Prior Year 0.55
  • Growth Rate Est. (year over year) -1.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.79 +0.70%
on 11/29/22
13.89 -7.27%
on 11/14/22
-0.69 (-5.08%)
since 10/28/22
3-Month
11.56 +11.37%
on 09/26/22
13.89 -7.27%
on 11/14/22
-0.55 (-4.10%)
since 08/29/22
52-Week
11.56 +11.37%
on 09/26/22
20.71 -37.79%
on 04/05/22
-4.04 (-23.88%)
since 11/26/21

Most Recent Stories

More News
Should Value Investors Buy Innoviva (INVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

INVA : 12.88 (-0.23%)
MRK : 108.84 (+0.36%)
Zacks.com featured highlights PBF Energy, Innoviva, Global Partners, Heritage-Crystal Clean and Sterling Infrastructure

PBF Energy, Innoviva, Global Partners, Heritage-Crystal Clean and Sterling Infrastructure have been highlighted in this Screen of The Week article.

GLP : 31.57 (+0.77%)
STRL : 31.42 (-2.24%)
PBF : 41.53 (-3.01%)
HCCI : 30.87 (-3.20%)
INVA : 12.88 (-0.23%)
5 Value Stocks With Attractive EV-to-EBITDA Ratios to Snap Up

We have screened value stocks PBF, INVA, GLP, HCCI and STRL based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.

GLP : 31.57 (+0.77%)
STRL : 31.42 (-2.24%)
PBF : 41.53 (-3.01%)
HCCI : 30.87 (-3.20%)
INVA : 12.88 (-0.23%)
Are Investors Undervaluing Innoviva (INVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

INVA : 12.88 (-0.23%)
MRK : 108.84 (+0.36%)
Innoviva (INVA) Q3 Earnings and Revenues Lag Estimates

Innoviva (INVA) delivered earnings and revenue surprises of -78.18% and 81.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

INVA : 12.88 (-0.23%)
XWEL : 0.3900 (-0.08%)
Innoviva: Q3 Earnings Snapshot

Innoviva: Q3 Earnings Snapshot

INVA : 12.88 (-0.23%)
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today reported financial results for the third...

INVA : 12.88 (-0.23%)
Eli Lilly (LLY) Q3 Earnings and Revenues Beat Estimates

Lilly (LLY) delivered earnings and revenue surprises of 0.51% and 0.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LLY : 363.95 (-0.50%)
INVA : 12.88 (-0.23%)
Is Bayer (BAYRY) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

BAYRY : 14.5420 (+0.46%)
INVA : 12.88 (-0.23%)
Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline

Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MRK : 108.84 (+0.36%)
INVA : 12.88 (-0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance,...

See More

Key Turning Points

3rd Resistance Point 13.17
2nd Resistance Point 13.07
1st Resistance Point 12.98
Last Price 12.88
1st Support Level 12.79
2nd Support Level 12.69
3rd Support Level 12.60

See More

52-Week High 20.71
Fibonacci 61.8% 17.21
Fibonacci 50% 16.14
Fibonacci 38.2% 15.06
Last Price 12.88
52-Week Low 11.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar